TY  - JOUR

T1  - The ErbB-tyrosine kinase inhibitor, neratinib, has anti-inflammatory effects in multimorbidity by increasing macrophage efferocytosis via the upregulation of MerTK

JO  - Journal of Inflammation

UR  - https://eprints.whiterose.ac.uk/id/eprint/239504

PY  - 2026/03/19

AU  - Bowden KA

AU  - Wright C

AU  - Clark S

AU  - Correa TF

AU  - Johnston SA

AU  - Marriott HM

AU  - Francis SE

AU  - Prince LR

ED  - 

DO  - DOI: 10.1186/s12950-026-00495-9

PB  - Springer Science and Business Media LLC

Y2  - 2026/03/30

ER  -